| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2025 | Nov 6, 2025 | Nuvectis Pharma, Inc. | Director | Buy | 90.0 | +11,000 | 9.67% | ✗ | $64.2K |
| May 12, 2022 | May 16, 2022 | Nuvectis Pharma, Inc. | Director | Buy | 90.0 | +3,000 | 9.16% | ✗ | $50.6K |